Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have Crohn's disease affecting the lower small intestine and the beginning of the large intestine, and who need surgery for this condition
- People who need surgery on their small intestine and/or large intestine for a reason other than Crohn's disease or ulcerative colitis (for example, cancer, a polyp, or a diverticulum)
Who may not be able to join:
- People who are vegetarian or vegan, have celiac disease, gluten sensitivity, an eating disorder, follow a special or restricted diet, or have been diagnosed with obesity or anorexia
- People who have previously had a portion of their intestine surgically removed
- People who have taken antibiotic or probiotic treatments in the 6 weeks before joining the trial
- People who have used rectal treatments (such as suppositories or enemas containing 5-ASA or corticosteroids) in the 6 weeks before joining the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Philippe ZERBIB, MD,PhD, University Hospital, Lille
Phone: 0320445962
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Quantification of Deoxynivalenol and its conjugated metabolites by Liquid Chromatography coupled to tandem Mass Spectrometry (LC-MS/MS).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.